Collplant Biotechnologies LTCLGN

13F holders, Q3 2024 (September 30)
12holders −3
3new positions
4sold out
$5.50avg. 13F price*

At the end of Q3 2024, 12 institutions reported holding Collplant Biotechnologies LT (CLGN) in their 13F filings, down 3 from Q2 2024. 3 opened new positions and 4 sold out. The largest holders were Pinnacle Associates Ltd. ($3.0M), Villere St Denis J & Co. LLC ($2.4M) and Brown Advisory Inc. ($593K).

Company
Collplant Biotechnologies LT
CUSIP
M2R51X116
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q1 2024: 12Q1 2024Q2 2024: 15Q2 2024Q3 2024: 12Q3 2024Q4 2024: 13Q4 2024Q1 2025: 15Q1 2025Q2 2025: 17Q2 2025Q3 2025: 18Q3 2025Q4 2025: 16Q4 2025Q1 2026: 20Q1 2026Q2 2026: 15Q2 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions3$216K
Exits4$24K

All 13F filers, Q2 2024 → Q3 2024: 168,343 shares bought and 105,643 shares sold, net +62,700 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 12 holders

Pinnacle Associates Ltd. 0.05% Reduce -17.1% 468,109 $3.0M
Villere St Denis J & Co. LLC 0.20% Add +24.4% 484,867 $2.4M
Brown Advisory Inc. 0.00% No change 119,465 $593K
AMH Equity Ltd 0.65% Add +31.1% 99,205 $493K
Benjamin Edwards Inc. 0.00% New 23,810 $112K
Pathstone Holdings, LLC 0.00% New 17,000 $84K
UBS Group AG 0.00% Add +67.3% 11,947 $59K
Wells Fargo & Company 0.00% New 4,000 $20K
Bank of America Corp. 0.00% Reduce -61.3% 2,825 $14K
Osaic Holdings, Inc. 0.00% Add +85.0% 370 $2K
National Bank of Canada 0.00% No change 250 $1K
Morgan Stanley 0.00% No change 1 $8

"% of holder's portfolio" is CLGN's weight in each manager's 13F, not the share of Collplant Biotechnologies LT the manager owns.